(2R,3R,4R,5R)-2-(6-Amino-9H-purin-9-yl)-5-(hydroxymethyl)-3-methyltetrahydrofuran-3,4-diol, 98%, 100mg

(2-Mercaptoethyl)pyrazine>98.0%(GC)1g

1-(4-tert-Butyl-benzenesulfonyl)-piperazine, 95.0%, 1g

7-Amino-alpha-tetralone, 97.0%, 1g

Pipetas medidoras tipo 3 clase AS, 10 ml, división, 0,1 ml, extremo con tapón de algodón, sí, 12 unidades

2-Bromo-thiophene-3-carbaldehyde, 95.0%, 1g

2-[2-(2-Chloro-ethoxy)-ethyl]-isoindole-1,3-dione, 95.0%, 10g

5-(2,4-dimethylbenzyl)-1,3,4-oxadiazol-2-amine, 95.0%, 250mg

(S)-2-(Pyrrolidin-3-yl)acetic acid, 95.0%, 1g

6-Oxo-1,6-dihydropyrazine-2-carboxylic acid, 95.0%, 1g

(1S,2S)-(+)-trans-1-Amino-2-indanol, 99.0%, 250mg

4-Cyclopropyl-2-fluoro-benzamide, 98%, 100mg

1-cloroadamantano, mínimo 98 %, para síntesis, 100 g, envase de vidrio